An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these accounts directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in users injecting substances of unknown origin.
Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.
Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.
Platform Response and Material Removal
Based on the social media company, the service has taken down violative material and prohibited related hashtags and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.
Digital Trading Operations
Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, positive reviews and detailed guides for preparing or injecting at residence.
Within moments of entering one community, a vendor posted contact information, where most transactions occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.
Product Information and Costs
Within these groups, posts show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant medical dangers”.
